NAC could also preserve the expression level of PGC1a and SirT1 (Supplementary Figure S2C), which further supports the role of SirT1/PGC1a in the treating effect of NAC in dealing with hepatic steatosis. This evidence concerns the gene SIRT1 and fatty liver disease.